Division of Social and Administrative Sciences, School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Department of Pharmaceutical Sciences, College of Pharmacy, Roseman University of Health Sciences, Utah, USA.
BMJ Open. 2018 Nov 25;8(11):e022803. doi: 10.1136/bmjopen-2018-022803.
To cluster the adherence behaviours of patients with type 2 diabetes based on their beliefs in medicines and illness perceptions and examine the psychosocial, clinical and sociodemographic characteristics of patient clusters.
Cross-sectional study.
A face-to-face survey was administered to patients at two family medicine clinics in the Midwest, USA.
One hundred and seventy-four ≥20-year-old, English-speaking adult patients with type 2 diabetes who were prescribed at least one oral diabetes medicine daily were recruited using convenience sampling.
Beliefs in medicines and illness perceptions were assessed using the Beliefs about Medicines Questionnaire and the Brief Illness Perception Questionnaire, respectively. Self-reported medication adherence was assessed using the Morisky Medication Adherence Scale. Psychosocial correlates of adherence, health literacy and self-efficacy were measured using the Newest Vital Sign and the Self-efficacy for Appropriate Medication Use, respectively. Two-step cluster analysis was used to classify patients.
Participants' mean age was 58.74 (SD=12.84). The majority were women (57.5%). Four clusters were formed (non-adherent clusters: ambivalent and sceptical; adherent clusters: indifferent and accepting). The ambivalent cluster (n=30, 17.2%) included low-adherent patients with high necessity beliefs, high concern beliefs and high illness perceptions. The sceptical cluster (n=53, 30.5%) included low adherent patients with low necessity beliefs but high concern beliefs and high illness perceptions. Both the accepting (n=40, 23.0%) and indifferent (n=51, 29.3%) clusters were composed of patients with high adherence. Significant differences between the ambivalent, sceptical, accepting and indifferent adherent clusters were based on self-efficacy, illness perception domains (treatment control and coherence) and haemoglobin A1c (p<0.01).
Patients with diabetes in specific non-adherent and adherent clusters still have distinct beliefs as well as psychosocial characteristics that may help providers target tailored medication adherence interventions.
根据患者对药物和疾病认知的信念对 2 型糖尿病患者的依从行为进行聚类,并检查患者聚类的心理社会、临床和社会人口统计学特征。
横断面研究。
在美国中西部的两家家庭医学诊所进行面对面调查。
采用便利抽样法招募了 174 名年龄≥20 岁、讲英语、每天服用至少一种口服糖尿病药物的 2 型糖尿病成年患者。
使用信念量表评估患者对药物的信念和疾病认知,使用简明疾病认知问卷分别评估自我报告的药物依从性。使用最新生命体征和适当用药自我效能量表分别测量心理社会相关性、健康素养和自我效能。采用两步聚类分析对患者进行分类。
参与者的平均年龄为 58.74(SD=12.84)岁。大多数是女性(57.5%)。共形成了 4 个聚类(不依从聚类:矛盾和怀疑;依从聚类:冷漠和接受)。矛盾聚类(n=30,17.2%)包括低依从性、高必要性信念、高关注信念和高疾病认知的患者。怀疑聚类(n=53,30.5%)包括低依从性、低必要性信念但高关注信念和高疾病认知的患者。接受聚类(n=40,23.0%)和冷漠聚类(n=51,29.3%)均由高依从性患者组成。在自我效能、疾病认知领域(治疗控制和一致性)和糖化血红蛋白(HbA1c)方面,矛盾、怀疑、接受和冷漠的依从性聚类之间存在显著差异(p<0.01)。
具有特定不依从和依从聚类的糖尿病患者仍然具有独特的信念和心理社会特征,这可能有助于提供者针对特定的药物依从性干预措施。